169 related articles for article (PubMed ID: 37368350)
61. Head-and-neck stages I and II extranodal non-Hodgkin's lymphomas: real classification and selection for treatment modality.
Sasai K; Yamabe H; Kokubo M; Shibata T; Oya N; Nagata Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):153-60. PubMed ID: 10924985
[TBL] [Abstract][Full Text] [Related]
62. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
63. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
64. [Clinicopathological characteristics and prognosis of non-Hodgkin lymphoma in oral and maxillofacial regions: An analysis of 369 cases].
Su Q; Peng X; Zhou CX; Yu GY
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):13-21. PubMed ID: 36718684
[TBL] [Abstract][Full Text] [Related]
65. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract][Full Text] [Related]
66. [Prognostic significance of NCCN-International Prognostic Index (NCCN-IPI) for patients with peripheral T-cell lymphoma treated with CHOP-based chemotherapy].
Zhang MC; Xu PP; Zhong HJ; Zhao X; Zhao WL; Cheng S
Zhonghua Xue Ye Xue Za Zhi; 2017 Sep; 38(9):772-777. PubMed ID: 29081194
[No Abstract] [Full Text] [Related]
67. A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan.
Pei SN; Wang MC; Ma MC; Kuo CY; Liao CK; Qiu H; Rothwell LA; Liu Y
Sci Rep; 2021 May; 11(1):10069. PubMed ID: 33980914
[TBL] [Abstract][Full Text] [Related]
68. Non-Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand.
Intragumtornchai T; Bunworasate U; Wudhikarn K; Lekhakula A; Julamanee J; Chansung K; Sirijerachai C; Norasetthada L; Nawarawong W; Khuhapinant A; Siritanaratanakul N; Numbenjapon T; Prayongratana K; Chuncharunee S; Niparuck P; Suwanban T; Kanitsap N; Wongkhantee S; Pornvipavee R; Wong P; Makruasi N; Wannakrairot P; Assanasen T; Sukpanichnant S; Boonsakan P; Kanoksil W; Ya-In C; Kayasut K; Mitranun W; Warnnissorn N
Hematol Oncol; 2018 Feb; 36(1):28-36. PubMed ID: 28332735
[TBL] [Abstract][Full Text] [Related]
69. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
[TBL] [Abstract][Full Text] [Related]
70. International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI.
Ruppert AS; Dixon JG; Salles G; Wall A; Cunningham D; Poeschel V; Haioun C; Tilly H; Ghesquieres H; Ziepert M; Flament J; Flowers C; Shi Q; Schmitz N
Blood; 2020 Jun; 135(23):2041-2048. PubMed ID: 32232482
[TBL] [Abstract][Full Text] [Related]
71. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.
d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS
Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929
[TBL] [Abstract][Full Text] [Related]
72. Toward Optimization of Cancer Care in Sub-Saharan Africa: Development of National Comprehensive Cancer Network Harmonized Guidelines for Sub-Saharan Africa.
Mutebi M; Adewole I; Orem J; Abdella K; Coker O; Kolawole I; Komen A; Munema A; Ndlovu N; O'Brien M; Koh WJ; Carlson R;
JCO Glob Oncol; 2020 Sep; 6():1412-1418. PubMed ID: 32970487
[TBL] [Abstract][Full Text] [Related]
73. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
74. Retrospective audit of clinico-pathologic features and treatment outcomes in a cohort of elderly non-Hodgkin's lymphoma patients in a tertiary cancer center.
Nair CK; Patil VM; Raghavan V; Babu S; Nayanar S
Indian J Cancer; 2015; 52(4):541-4. PubMed ID: 26960470
[TBL] [Abstract][Full Text] [Related]
75. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
[TBL] [Abstract][Full Text] [Related]
76. Waldeyer's ring lymphomas: a clinical study from the Comprehensive Cancer Center West population based NHL registry.
Krol AD; Le Cessie S; Snijder S; Kluin-Nelemans JC; Kluin PM; Noorduk EM
Leuk Lymphoma; 2001; 42(5):1005-13. PubMed ID: 11697617
[TBL] [Abstract][Full Text] [Related]
77. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
78. Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases.
Perry AM; Diebold J; Nathwani BN; MacLennan KA; Müller-Hermelink HK; Bast M; Boilesen E; Armitage JO; Weisenburger DD
Br J Haematol; 2016 Mar; 172(5):699-708. PubMed ID: 26684877
[TBL] [Abstract][Full Text] [Related]
79. Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement.
Visco C; Medeiros LJ; Jones D; Smith T; Rodriguez MA; McLaughlin P; Romaguera J; Cabanillas F; Sarris AH
Ann Oncol; 2002 Aug; 13(8):1290-9. PubMed ID: 12181254
[TBL] [Abstract][Full Text] [Related]
80. Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study.
Maggen C; Dierickx D; Lugtenburg P; Laenen A; Cardonick E; Shmakov RG; Bellido M; Cabrera-Garcia A; Gziri MM; Halaska MJ; Ottevanger PB; Van Calsteren K; O'Laughlin A; Polushkina E; Van Dam L; Avivi I; Vandenberghe P; Woei-A-Jin FJSH; Amant F;
Lancet Haematol; 2019 Nov; 6(11):e551-e561. PubMed ID: 31564649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]